New Products Digest
SEE OTHER BRANDS

Your top news on consumer products

New Products Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Products Digest.

Press releases published on September 7, 2025

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi …

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 - IRBT

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 - IRBT

Faruqi …

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: …

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres

HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres

BERLIN, Sept. 07, 2025 (GLOBE NEWSWIRE) -- HKC Group, a global display manufacturer, makes its European debut at IFA 2025 with a coordinated showcase across its three brands—HKC, KOORUI, and ANTGAMER—each unveiling a breakthrough product. The move …

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de datos de código abierto para el Estudio genético sobre el …

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing

Strongest Amanita Mushroom Gummies Announced by MoonWlkr for 2025 With Updated Formula and Expanded Testing

Salt Lake City, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only and does not provide medical advice. Some links in this article may be promotional affiliate links. If readers click on these links and complete a …

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands

Welnax NeuroRelief Pro Officially Launches in 2025 as Consumer Demand for Nerve Relief Devices Expands

New York, Sept. 06, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions